• Lanabecestat (AZD3293) in Alzheimer’s Disease Research Workf

  2026-05-06

  Lanabecestat (AZD3293) is redefining Alzheimer’s disease research by enabling precise, synaptic-sparing amyloid-beta pathway modulation. This article delivers actionable, evidence-based strategies to optimize experimental design, troubleshoot common issues, and harness the full translational potential of this potent BACE1 inhibitor.

• Localized Olaparib Nanoparticle Hydrogel for Post-Surgical G

  2026-05-05

  This study introduces a novel bioadhesive sprayable hydrogel system incorporating polymer-coated nanoparticles of etoposide and Olaparib (AZD2281) for localized drug delivery following surgical resection of glioblastoma. The approach demonstrates improved biocompatibility, sustained drug release, and potential for enhanced therapeutic targeting of residual brain tumor cells, supporting future translational research in localized cancer treatment.

• (S)-(+)-Dimethindene maleate: Technical Guide for M2 Antagon

  2026-05-05

  (S)-(+)-Dimethindene maleate is a selective M2 muscarinic receptor antagonist optimized for receptor signaling pathway studies in autonomic, cardiovascular, and respiratory research. Use where precise antagonism of M2 and H1 receptors is required and avoid applications outside these validated pathways. Not intended for diagnostic or clinical use.

• QSHXO Attenuates MASLD via Autophagy and Ferroptosis Modulat

  2026-05-04

  This study demonstrates that Qushi Huoxue ointment (QSHXO) alleviates metabolic associated steatotic liver disease (MASLD) in mice by activating autophagy and inhibiting ferroptosis. The findings clarify the mechanistic basis for QSHXO's efficacy, providing direction for targeted therapeutic research in liver disease.

• Neuroligin 1 Loss in Striatal D2-MSNs Drives Repetitive Beha

  2026-05-04

  This study demonstrates that deletion of Neuroligin 1 in striatal D2 receptor-expressing medium spiny neurons results in their hyperactivation, leading to increased repetitive behaviors in mice. By integrating behavioral, molecular, and single-nucleus RNA sequencing approaches, the authors implicate PKC overactivation and clarify cell-circuit mechanisms underlying core autism symptoms.

• YM-155 Hydrochloride: Advanced Survivin Inhibitor for Cancer

  2026-05-03

  YM-155 hydrochloride enables precise, data-driven modulation of survivin in apoptosis inhibitor research, offering nanomolar potency and robust selectivity. This guide details optimized workflows, comparative insights, and troubleshooting strategies that accelerate translational cancer studies with APExBIO’s trusted reagent.

• Organic Cation Transporter Responses to Xenobiotics in Aedes

  2026-05-02

  Kennel and Rouhier's 2025 study investigates how Aedes aegypti mosquitoes manage and expel xenobiotic compounds, focusing on the expression of putative organic cation transporters (OCTs/OCTNs) after exposure to synthetic dyes and the mesalamine dimer Olsalazine Sodium. Their findings reveal that while transporter gene expression remains largely unchanged, the chemical structure of xenobiotics substantially influences excretion dynamics and mosquito mortality, pointing to potential molecular targets for vector control.

• Ibrexafungerp Efficacy Against Fluconazole-Resistant Candida

  2026-05-02

  This study demonstrates that ibrexafungerp (MK 3118) exhibits consistent in vitro activity against fluconazole-resistant Candida auris and achieves significant efficacy in a delayed-therapy animal model of invasive candidiasis. These results highlight its potential as an oral antifungal for multidrug-resistant Candida infections, where treatment options remain limited.

• GSK343: Precision EZH2 Inhibitor for Epigenetic Cancer Resea

  2026-05-01

  GSK343 empowers researchers to dissect PRC2-mediated gene silencing with unmatched selectivity and potency, advancing epigenetic cancer research and stem cell studies. This guide demystifies applied workflows, troubleshooting, and protocol innovations anchored in the latest discoveries on telomerase regulation.

• Pentoxifylline Attenuates LPS-Induced Hyperinflammation in N

  2026-04-30

  This study provides mechanistic insight into how Pentoxifylline, a non-specific phosphodiesterase inhibitor, modulates hyperinflammatory responses in monocytes from preterm infants exposed to bacterial LPS in vitro. The findings highlight age-dependent immunomodulatory effects, with implications for neonatal sepsis research and future therapeutic strategies.

• Pomalidomide (CC-4047): Optimizing Hematological Malignancy

  2026-04-30

  Pomalidomide (CC-4047) enables precision modulation of the tumor microenvironment and erythroid differentiation in hematological malignancy research. This article details advanced workflows, essential troubleshooting, and evidence-backed protocol parameters, translating recent genomic insights into actionable laboratory strategies.

• MitMAB (SKU B7620): Precision Inhibition for Endocytosis Res

  2026-04-29

  This article addresses practical challenges in cell-based endocytosis and cytotoxicity assays, illustrating how MitMAB (SKU B7620) delivers reliable and reproducible inhibition of dynamin GTPase activity. Scenario-driven insights guide researchers in optimizing intracellular trafficking studies and highlight MitMAB's evidence-backed performance in physiologically relevant organoid models.

• Neuromedin S (rat): Technical Guidance for GPCR Signaling As

  2026-04-29

  Neuromedin S (rat) provides a defined endogenous ligand for activating neuromedin U receptor signaling in controlled GPCR/G protein assays. This product addresses the need for reproducible, validated peptide reagents in studies of energy homeostasis and stress response in rat models. It is intended solely for research use and is not suitable for diagnostic or therapeutic applications.

• HyperFluor™ 488 Goat Anti-Rabbit IgG: Technical Use & QC Gui

  2026-04-28

  HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody addresses the need for sensitive and specific detection of rabbit primary antibodies in fluorescence-based assays. It is best suited for immunofluorescence, flow cytometry, and microscopy where high signal amplification and low cross-reactivity are required. This reagent is not suitable for applications outside its validated scope, such as direct detection of non-rabbit primaries or non-fluorescent workflows.

• Baicalein for Apoptosis and Inflammation: Applied Workflows

  2026-04-28

  Baicalein (5,6,7-trihydroxy-2-phenylchromen-4-one) stands out as a high-purity research compound for dissecting apoptosis and inflammation pathways, thanks to its potent inhibition of arachidonic acid metabolism. This guide delivers actionable protocols, troubleshooting strategies, and comparative insights to maximize experimental rigor and reproducibility.

16522 records 1/1102 page Next 12345 下5页 Last page